• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov18
Bailitiantian's Iza-bren Reaches Dual Primary Endpoints in Phase III Clinical Trials for Esophageal Cancer
00:26
Oct26
BIOKIN released FY2024 9 Months earnings on October 26 (BJT), actual revenue HKD 6.139 B, actual EPS HKD 10.9558
15:00
BIOKIN released FY2025 9 Months Earnings on October 26, 2025 (BJT) with actual revenue of HKD 2.257 B and EPS of HKD -1.3381
15:00
BIOKIN released FY2025 Q3 earnings on October 26, 2025 (BJT) with actual revenue of HKD 2.071 B and EPS of HKD 1.6838
15:00
BIOKIN released FY2024 Q3 earnings on October 26 (BJT), actual revenue HKD 121.74 M, actual EPS HKD -1.6612
15:00
Aug19
BIOKIN released FY2024 Q2 earnings on August 19, 2025 (BJT) with actual revenue of HKD 97.36 M and EPS of HKD -0.9085
15:00

Schedules & Filings

Schedules
Filings
Nov17
IPO(CST)

Listing Price HKD 347.5 ~ 389

Oct26
Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 2.071 B, Net Income 681.52 M, EPS 1.6838

Aug30
Earning Release(CST)

FY2025 Semi-Annual Earning Release

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06928
0.300
+42.86%
+0.090
02442
5.670
+38.29%
+1.570
02570
155.000
+29.38%
+35.200
08059
0.018
+28.57%
+0.004
01862
0.015
+25.00%
+0.003
01721
0.200
+22.70%
+0.037
00660
0.245
+20.10%
+0.041
02012
0.460
+19.48%
+0.075
01152
0.310
+19.23%
+0.050
03928
10.350
+17.61%
+1.550
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy